Table 3 Comparative analysis of modeling indicators for patients using the training set and validation set
Characteristics | Training Set(n = 189) | Validation Set(n = 81) | P value |
|---|---|---|---|
Age (years) |  |  | > 0.05 |
 < 60 | 83(43.92) | 32(39.51) |  |
 ≥ 60 | 106(56.08) | 47(58.02) |  |
BMI ≥ 24 kg/m2 | 99(52.38) | 41(50.62) | > 0.05 |
Diabetes | 115(60.85) | 49(60.49) | > 0.05 |
Hypertension | 118(62.43) | 48(59.26) | > 0.05 |
Classification of lesion location |  |  | > 0.05 |
 Aortoiliac disease | 67(35.45) | 28(34.57) |  |
 Femoropopliteal disease | 45(23.81) | 17(20.99) |  |
Surrounding type | 77(40.74) | 31(38.27) | Â |
Antiplatelet drugs(used) | 118(62.43) | 47(58.02) | > 0.05 |
TG/(mmol/L) | 2.16 ± 0.53 | 2.20 ± 0.56 | > 0.05 |
FIB/(g/L) | 3.32 ± 0.52 | 3.38 ± 0.53 | > 0.05 |
D-D/(mg/L) | 0.57 ± 0.09 | 0.58 ± 0.10 | > 0.05 |